首页> 外文期刊>Trials >Effect of multidisciplinary intensive targeted care in improving diabetes mellitus?outcomes: a randomized controlled pilot study – the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program
【24h】

Effect of multidisciplinary intensive targeted care in improving diabetes mellitus?outcomes: a randomized controlled pilot study – the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program

机译:多学科强化靶心护理改善糖尿病的影响:一种随机对照试验研究 - 新加坡(理想)计划中的综合糖尿病教育,意识和生活方式改造

获取原文
           

摘要

There is a global pandemic of type 2 diabetes mellitus (T2DM), especially in Asia. Singapore has a prevalence of T2DM at 10.5%, which is higher than the world average of 8.8%. Multiple studies have shown that multidisciplinary, team-based, coordinated care has been associated with improved measures of quality care and reduced healthcare utilization. Patients with poor glycemic control and nephropathy are at the highest risk of developing cardiovascular complications and renal failure. In this study, we aimed to investigate the impact of intensive multidisciplinary diabetes mellitus care with patient empowerment versus routine clinical care on the rate of progression of micro and macrovascular complications and peripheral atherosclerotic burden, as measured by changes in femoral intima-media thickness (IMT) in patients with persistently elevated HbA1c and nephropathy. The study is a single-center randomized controlled trial (RCT) with two study arms - intensive diabetes mellitus care versus routine clinical care. Patients in the intensive arm will receive care from a multidisciplinary team consisting of an endocrinologist, diabetes nurse educator, dietitian, renal pharmacist and medical social worker for counselling. In addition, patients will be provided with tools for self-care empowerment such as glucometers, blood pressure monitors and android tablets to facilitate care, monitoring and education. Patients in the routine clinical care arm will receive standard clinical care. Follow up (FU) will be for 3?years. Primary outcomes include cardiovascular events, rate of progression of nephropathy and development of end-stage renal disease. Secondary endpoints include the proportions of patients with documented improved control of cardiovascular risk factors (HbA1c, blood pressure, low density lipoprotein-C (LDL-C), reduction in body weight), frequency of hypoglycemia, hospitalization days and changes in femoral IMT. We will also examine the prevalence of peripheral atherosclerosis and the predictive value and usability of lower extremity arterial ultrasound to predict cardio-cerebrovascular events, amputation and peripheral intervention. Diabetes mellitus carries significant healthcare costs. Patients with poor glycemic control and nephropathy are at highest risk of developing cardiovascular complications and renal failure. Intensive diabetes mellitus care with patient empowerment may lead to sustained glycemic control, reduction of clinical complications and progression of nephropathy, and incidence of cardiovascular complications. ClinicalTrials.gov, NCT03413215 . Registered on 29 January 2019.
机译:全球大流行于2型糖尿病(T2DM),特别是在亚洲。新加坡的T2DM患病率为10.5%,高于世界平均水平为8.8%。多学习已经表明,多学科,基于团队的协调护理与质量护理的改善措施和减少的医疗利用率有关。血糖控制差和肾病患者处于发育心血管并发症和肾功能衰竭的最高风险。在这项研究中,我们旨在调查密集型多学科糖尿病MELLITUS MELLITUS MELLITUS MELLITUS患者对患者赋予常规临床护理的影响,以对微生物和大血管并发症和外周动脉粥样硬化负担的进展速度,如股骨内介质厚度的变化(IMT )在持续升高的HBA1C和肾病患者中。该研究是一个单中心随机对照试验(RCT),具有两项研究武器 - 密集型糖尿病Mellitus护理与常规临床护理。密集臂中的患者将从内分泌学家,糖尿病护士教育家,营养师,肾脏药剂师和医学社会工作者组成的多学科团队中得到保险。此外,患者还将提供自我保健赋权的工具,如血糖仪,血压监测器和Android平板电脑,以促进护理,监测和教育。常规临床护理中的患者将获得标准的临床护理。跟进(傅)将是3年的时间。主要结果包括心血管事件,肾病率和末期肾病的发展。辅助端点包括记录的心血管危险因素(HBA1C,血压,低密度脂蛋白-C(LDL-C),体重还原,体重还原的患者的比例,低血糖血症,住院日和股骨IMT的变化。我们还将研究外周动脉粥样硬化的患病率和下肢动脉超声的预测值和可用性,以预测心血管血管事件,截肢和外围干预。糖尿病患有显着的医疗费用。血糖控制差和肾病患者具有最高的风险,以发育心血管并发症和肾衰竭。患有患者赋权的密集糖尿病护理可能导致血糖控制的持续血糖控制,降低肾病的临床并发症,以及心血管并发症的发生率。 ClinicalTrials.gov,NCT03413215。注册2019年1月29日。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号